Noticias del mercado de valores

Últimas noticias financieras · Actualizado Jul 18, 2026

NVDA
▬ mixed

Yahoo Finance lanza AlphaSpace: Aquí te mostramos cómo puedes usarlo para prepararte para el día de ganancias de Nvidia

Yahoo Finance unleashes AlphaSpace: Here's how you can use it to prepare for Nvidia earnings day

The panel's discussion on Yahoo Finance's AlphaSpace launch and NVDA's earnings prospects is mixed, with most participants expressing caution due …

Yahoo Finance · May 19, 2026
EEA
▬ mixed

zerohash europe obtiene licencia holandesa de EMI para pagos con stablecoin

zerohash europe obtains Dutch EMI licence for stablecoin payments

While Zerohash Europe's EMI license from De Nederlandsche Bank complements its MiCAR authorization, opening stablecoin payment flows across the EEA, …

Yahoo Finance · May 19, 2026
IOT
▬ mixed

El fallo de la Corte Suprema sobre la responsabilidad de los corredores es un impulso para la plataforma de seguridad de Samsara

SCOTUS broker liability ruling a tailwind for Samsara’s safety platform

The Montgomery ruling may increase demand for objective telematics and coaching data, potentially benefiting companies like Samsara, but adoption could …

Yahoo Finance · May 19, 2026
ES F P S
▼ bear…

Bolsa hoy: Futuros del Dow, S&P 500, Nasdaq caen mientras los rendimientos crecientes mantienen la presión

Stock market today: Dow, S&P 500, Nasdaq futures slide as rising yields keep up pressure

The panel consensus is bearish, with rising 10-year yields above 4.6% and potential Nvidia earnings disappointment driving a re-rating of …

Yahoo Finance · May 19, 2026
MDCXW
▼ bear…

Medicus Pharma Ltd. (MDCXW) Informa Progreso de la FDA y Amplía Perspectivas Clínicas para 2026

Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook

Medicus Pharma (MDCXW) faces acute financing pressure with only 2 quarters of runway, despite recent clinical progress. Dilution is likely …

Yahoo Finance · May 19, 2026
MVIS
▼ bear…

MicroVision, Inc. (MVIS) se asocia con Avular para avanzar en sistemas de drones autónomos

MicroVision, Inc. (MVIS) Partners With Avular to Advance Autonomous Drone Systems

The panel is bearish on MicroVision (MVIS) due to high execution risk, lack of binding commitments, and intense competition in …

Yahoo Finance · May 19, 2026
FFAI
▼ bear…

¿Está Faraday Future Intelligent Electric Inc. (FFAI) emergiendo como una acción de robótica de IA a tener en cuenta en 2026?

Is Faraday Future Intelligent Electric Inc. (FFAI) Emerging as an AI Robotics Stock to Watch in 2026?

The panel consensus is overwhelmingly bearish on FFAI's current trajectory, citing microscopic revenue, heavy cash burn, and questionable execution capabilities …

Yahoo Finance · May 19, 2026
CYCU
▼ bear…

¿Está Cycurion, Inc. (CYCU) surgiendo como una acción de crecimiento de ciberseguridad con altos márgenes en 2026?

Is Cycurion, Inc. (CYCU) Emerging as a High-Margin Cybersecurity Growth Stock in 2026?

The panel consensus is bearish on CYCU, with the main takeaway being that the company's bullish revenue visibility narrative relies …

Yahoo Finance · May 19, 2026
S U
▬ mixed

¿Poca Nvidia? No es un Problema para Este ETF de Semiconductores

Not Much Nvidia? It's No Problem for This Semiconductor ETF

The panel discusses the outperformance of XSD, an equal-weighted semiconductor ETF, with mixed views on its sustainability and risks. While …

Yahoo Finance · May 19, 2026
CDLX
▼ bear…

Lake Street Recorta el Precio Objetivo de Cardlytics, Inc. (CDLX) a $1.25 en Medio de Expectativas de Reinicio

Lake Street Cuts Cardlytics, Inc. (CDLX) Price Target to $1.25 Amid Reset Expectations

The panel consensus is that CDLX is in a dire financial situation, with significant revenue declines, negative free cash flow, …

Yahoo Finance · May 19, 2026
HUMA
▼ bear…

¿Por qué el precio objetivo de Humacyte, Inc. (HUMA) fue elevado a pesar de la comercialización en etapa temprana?

Why Humacyte, Inc. (HUMA) Price Target Was Raised Despite Early-Stage Commercialization

The panel consensus is bearish on Humacyte's stock, with concerns about heavy cash burn, negligible revenue, and uncertainty around strategic …

Yahoo Finance · May 19, 2026
HRTX
▼ bear…

¿Por qué se redujo el precio objetivo de Heron Therapeutics, Inc. (HRTX) a $4 en H.C. Wainwright?

Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright?

The panelists agree that Heron Therapeutics' (HRTX) financial outlook is uncertain, with a key risk being the slow adoption of …

Yahoo Finance · May 19, 2026